cns.jpg (2811 bytes)

Subscription

Reprints

Journal Home
Contents
Editorial Board
Instructions for Contributors
Subscription Rates


© Neva Press, Inc. 2005


CNS Drug Reviews

Table of Contents

Volume 2, No. 2

145 F-0401:   A Novel Calcium Antagonist with PAF Antagonist Action, as a Potentially Cerebroprotective Drug for Patients with Ischemic Stroke
Hiroyuki Kato, Noriko Kase, Yutaka Hayashi and Kyuya Kogure
160 HA 1077:  A Novel Intracellular Calcium Antagonist. 1. Pharmacology
K. Sako, Y. Yonematsu, M. Tsuchiya and T. Asano
175 EMD 57445:  A Selective Sigma Receptor Ligand with the Profile of an Atypical Neuroleptic
G. D. Bartoszyk, H. M. Bender, J. Hellmann, C. Schorr and C. A. Seyfried
195 Therapeutic Potentials of Itasetron (DAU 6215), a Novel 5-HT3 Receptor Antagonist, in the Treatment of Central Nervous System Disorders
M. Beatrice Passani and Renato Corradetti
214 Cabergoline, a Promising Agent for the Treatment of Parkinson's Disease
R. Grondin and Paul J. Bédard
226 NE-100, a Novel Sigma Receptor Antagonist
Shigeru Okuyama and Atsuro Nakazato
238 Treatment Development Strategies for Alzheimer's Disease
Ernst Wülfert